project id: TCGA-LUAD; case submitter id: TCGA-53-A4EZ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 63; days to birth: -23201; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23201; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1071.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 163; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-53-A4EZ-01A-12; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 65.0; percent tumor nuclei: 75.0;